Company Deltagen Inc.

Equities

DGEN

US24783R1032

Pharmaceuticals

Delayed OTC Markets 10:17:52 2024-05-08 EDT 5-day change 1st Jan Change
0.0001 USD +9,900.00% Intraday chart for Deltagen Inc. 0.00% 0.00%

Business Summary

Deltagen, Inc. is a provider of drug discovery tools and services to the biopharmaceutical industry. The Company offers a suite of programs designed to manage the efficiency of drug discovery, including access to biological models, as well as both small-molecule and secreted protein drug targets. In addition, it offers target validation data in the areas of immunology and metabolic diseases. The Company's biology approach is designed to help clear the first and major hurdle of drug target discovery: lead validation. Its DeltaBase is a searchable database of in vivo-derived mammalian gene function information and gene targets. DeltaOne from the Company provides per-gene access to the knockout mice and/or phenotypic data needed.

Number of employees: 1

Sales per Business

USD in Million2012Weight Delta
Drug Discovery Tools
100.0 %
1 100.0 % -

Sales per region

USD in Million2012Weight Delta
United States
100.0 %
1 100.0 % -

Managers

Managers TitleAgeSince
Chief Executive Officer - 98-12-31

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer - 98-12-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 38,852,427 38,852,427 ( 100.00 %) 0 100.00 %

Shareholders

NameEquities%Valuation
Merrill Lynch Investment Managers, Inc.
0.008810 %
3,400 0.008810 % - $
Whatifi Asset Management, Inc.
0.004923 %
1,900 0.004923 % - $

Company contact information

Deltagen, Inc.

1900 South Norfolk Street Suite 105

94403, San Mateo

+

address Deltagen Inc.(DGEN)
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW